Condition: Prostate Carcinoma · Erectile Function · Genito Urinary Cancer · Sponsor: Regina Elena Cancer Institute
This prospective randomized controlled trial (RCT) is designed to provide high level evidence on the efficacy of Low-intensity Extracorporeal Shock Wave Therapy (Li-ESWT) in the treatment of post-Robot-Assisted (RA) Radical Prostatectomy (RP) erectile dysfunction (ED) in addition to PDE5 inhibitors (PDE5i) versus PDE5i alone. Our hypothesis is that early andrological rehabilitation that combines Li-ESWT and PDE5i could lead to faster and better recovery of valid erections for intercourse, with a greater rate of postoperative International Index of Erectile Function-5 (IIEF-5) compared to patients receiving PDE5i alone.
This description comes directly from the study's public registry record.
Giuseppe Simone · 0652665005 · giuseppe.simone@ifo.it
Riccardo Mastroianni · 0652665005 · riccardo.mastroianni@ifo.it
Always discuss trial participation with your own doctor first.
| IRCCS "Regina Elena" National Cancer Institute | Rome, RM, Italy | Recruiting |
| IRCCS "Fondazione G. Pascale" National Cancer Institute | Naples, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06717711